Trial Profile
Phase II study of Colistin/zidovudine.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 Apr 2018
Price :
$35
*
At a glance
- Drugs Colistin/zidovudine (Primary)
- Indications Urinary tract infections
- Focus Therapeutic Use
- 26 Apr 2018 New trial record
- 16 Mar 2018 According to the Helperby Therapeutics media release, company plans to initiate this trial later this year.